menu search

Atara biotherapeutics, inc. (atra) q3 2023 earnings call transcript

Atara Biotherapeutics, Inc. (NASDAQ:ATRA ) Q3 2023 Results Conference Call November 1, 2023 9:00 AM ET ...

November 4, 2023, 11:45 am

Elliott wave analysis of eurusd – november 6th, 2023

EURUSD gained a lot of ground last week after the Fed kept rates steady and economic data showed inflation was cooling. Can this be the beginning of a...

November 4, 2023, 8:34 am

Elliott wave analysis of usdjpy – november 6th, 2023

A year ago, USDJPY failed to conquer 152.00 and then fell 16% over the next three months. Last week, its second attempt proved unsuccessful, as well. ...

November 4, 2023, 8:06 am

Shareholder investigation: halper sadeh llc investigates slgc, sp, mrtx

NEW YORK, Nov. 04, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential vio...

November 4, 2023, 4:00 am

U.s. ipo weekly recap: biotech lexeo stumbles after $100 million ipo

Two IPOs are currently scheduled for the week ahead, although some small issuers may join the calendar late. As of 11/2/2023, the Renaissance IPO Inde...

November 4, 2023, 12:21 am

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Oncolytics biotech inc. (oncy) q3 2023 earnings call transcript

Oncolytics Biotech Inc. (NASDAQ:ONCY ) Q3 2023 Earnings Conference Call November 3, 2023 8:30 AM ET Com...

November 3, 2023, 9:05 pm

Sensei biotherapeutics reports favorable clinical data for sns-101 at 2023 sitc annual meeting

– Clinical dose escalation data for SNS-101 monotherapy show well tolerated safety profile, potentially best-in-class pharmacokinetics, and encourag...

November 3, 2023, 8:05 pm

Taysha gene therapies: tsha-102's potential is a 'buy'

Taysha Gene Therapies is a biotech stock focused on developing gene therapies for monogenic CNS disease...

November 3, 2023, 7:41 pm

Credicorp ltd. (bap) q3 2023 earnings conference call transcript

Credicorp Ltd. (NYSE:BAP ) Q3 2023 Earnings Conference Call November 3, 2023 10:30 AM ET Company Participants Milagros Ciguenas - IRO Cesar Rios - CFO...

November 3, 2023, 4:50 pm

Bitcoin mining stocks climb this week as btc hovers near 17-month high

Bitcoin mining stocks soared Thursday as bitcoin (BTC) itself traded around a 17-month high. Shares of U.S.-listed mining companies such as Marathon D...

November 3, 2023, 4:46 pm

Diasorin s.p.a. (dsrlf) q3 2023 earnings call transcript

DiaSorin S.p.A. (OTCPK:DSRLF) Q3 2023 Earnings Conference Call November 3, 2023 11:30 AM ET Company Participants Carlo Rosa - Chief Executive Officer ...

November 3, 2023, 3:28 pm

The bmw xm is business class, but the dodge durango is easier to overlook

Hannah Elliott, Bloomberg Businessweek columnist, joins to Bloomberg Radio for this week's What's Matt ...

November 3, 2023, 2:29 pm

Puma biotech (pbyi) q3 earnings beat, revenues lag estimates

Puma Biotech's (PBYI) third-quarter 2023 earnings beat estimates, while revenues miss the same. The com...

November 3, 2023, 1:32 pm

Longeveron to report third quarter 2023 results and provide corporate update on november 10, 2023

MIAMI, Nov. 03, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage b...

November 3, 2023, 12:00 pm

This stock just dropped by 15%: is it a buy?

Sanofi's third-quarter results weren't great, and the company announced a business separation. The biot...

November 3, 2023, 10:07 am


Search within

Pages Search Results: